Sign in
Taking people in United StatesNo phase

Supporting direct breastfeeding for babies born with congenital heart disease

Tests ways to help mothers breastfeed babies with congenital heart disease.

Key facts

Who runs it
Carelon Research
Where
Ann Arbor, Atlanta, Aurora, Boston, Charleston, Chicago, Cincinnati, Kansas City, Lexington, Los Angeles, Memphis, New York, Phoenix, Pittsburgh, Salt Lake City, and St Louis, United StatesSee the 17 sites
Trial code
Registry title
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease
Status
Recruiting
People taking part
266 people, planned
Started
22 Jul 2026
Expected to end
Aug 2030
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD)
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for mothers and their babies with congenital heart disease (a heart problem present at birth). It tests ways to help mothers breastfeed directly.

Age
Mothers 18 Years and older. Babies join from birth.
Sex
Mothers of any sex listed as ALL; babies of any sex.
Disease stage
The unborn baby or newborn has congenital heart disease and is expected to need heart surgery or a catheter procedure in the first 30 days of life. The baby is admitted to an intensive care unit (CICU or NICU) at a trial center in the 1st week of life.

Main reasons for not taking part

  • Baby born before 36 weeks of pregnancy, or birthweight below the 3rd percentile for gestational age.
  • Baby with a known genetic disorder likely to affect breastfeeding, such as trisomy 21 or cleft palate.
  • Mother with a severe, untreated mental health condition or substance use disorder.
  • Mother with moderate to severe intellectual disability or unable to give consent.
  • Any condition of mother or baby that makes direct breastfeeding or taking part unsafe.

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Pregnant individual carrying a fetus diagnosed with CHD or biological mother of an infant diagnosed with CHD in the neonatal period
  • Fetus or newborn with CHD anticipated to require cardiac surgery or transcatheter intervention in the first 30 days of life
  • Admission to the ICU (either CICU or NICU) at participating center in 1st week of life and for whom cardiac surgical or transcatheter intervention is anticipated in the first 30 days of life
  • Willing to comply with protocol and provide written informed consent

Who cannot take part

  • Mother, fetal, or infant medical condition determined by a treating clinician to be contraindicative to study participation
  • Mother with a severe, untreated psychiatric condition, substance use disorder, or other circumstances that, in the opinion of the investigator, would interfere with engagement with study tasks or safe participation in the trial
  • Infant with known genetic disorder likely to impact breastfeeding, such as trisomy 21 or cleft palate
  • Medical condition or congenital anomaly that precludes safe direct breastfeeding for the infant as determined by investigator
  • Infant birthweight <3rd percentile for gestational age
  • Infant gestational age < 36 weeks
  • Mother with a moderate to severe intellectual disability or is otherwise unable to provide informed consent

Other criteria

  • Both mothers and infants are study participants

Where in United States

  • University of Michigan Health System, Ann ArborAnn Arbor, United StatesContact: Principal InvestigatorTaking people
  • Children's Healthcare of AtlantaAtlanta, United StatesContact: Principal InvestigatorTaking people
  • Children's Hospital ColoradoAurora, United StatesContact: Principal InvestigatorNot yet recruiting
  • Boston Children's HospitalBoston, United StatesContact: Principal InvestigatorNot yet recruiting
  • Medical University of South CarolinaCharleston, United StatesContact: Principal InvestigatorTaking people
  • Lurie Children's HospitalChicago, United StatesContact: Principal InvestigatorNot yet recruiting
  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Principal InvestigatorTaking people
  • Children's Mercy HospitalKansas City, United StatesContact: Principal InvestigatorNot yet recruiting
  • Golisano Children's at UKLexington, United StatesContact: Principal InvestigatorNot yet recruiting
  • Children's Hospital of Los AngelesLos Angeles, United StatesContact: Principal InvestigatorNot yet recruiting
  • Le Bonheur Children's HospitalMemphis, United StatesContact: Principal InvestigatorTaking people
  • Children's Hospital of New YorkNew York, United StatesContact: Principal InvestigatorNot yet recruiting
  • Icahn School of Medicine at Mount SinaiNew York, United StatesContact: Principal InvestigatorNot yet recruiting
  • Phoenix Children s HospitalPhoenix, United StatesContact: Principal InvestigatorNot yet recruiting
  • University of Pittsburgh Medical CenterPittsburgh, United StatesContact: Principal InvestigatorNot yet recruiting
  • Primary Children's Medical CenterSalt Lake City, United StatesContact: Principal InvestigatorNot yet recruiting
  • Washington University School of MedicineSt Louis, United StatesContact: Principal InvestigatorNot yet recruiting

About the trial

What the trial wants to find out

The primary objective of this study is to enhance the rates of direct breast feeding (DBF) among infants with congenital heart disease (CHD), and to gain insights into the implications of DBF on key metrics of child and parent well-being. A multicenter parallel cluster platform design will be employed. The intervention will be a multifaceted approach to enhance direct breastfeeding. Participating sites will be randomized into either intervention (strategies to enhance direct breastfeeding) or conventional care.

The 2 groups in the trial

  • Breastfeeding clinical practice guideline (CPG)Treatment being tested

    The clinical practice guideline (CPG) intervention will be developed by the clinical centers randomized to this arm. The intervention plan will likely include: 1) prenatal counseling; 2) viewing a video on breastfeeding CHD infants; 3) individual counseling by a registered lactation consultant (RLC), 4) weekly personal contact in-hospital by the RLC, 5) frequent contact post discharge by the RLC through the first year or until breastfeeding is discontinued, 6) provision of high-quality breast pumps, 7) incentive to continue with pumping breastmilk or direct breastfeeding.

    Treatment: Breastfeeding clinical practice guideline (CPG) for congenital heart disease (CHD)

  • Standard of CareNo study treatment, for comparison

    This arm will receive standard of care with respect to breastfeeding at the clinical centers randomized to this group.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
BOND: Direct Breastfeeding to Enhance Maternal and Infant Health in Congenital Heart Disease
Plain-language title
Supporting direct breastfeeding for babies born with congenital heart diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
10 September 2026